Meiogenix Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series B
- (In Progress)
- Latest Deal Amount
-
$17.6M
- Investors
-
10
Meiogenix General Information
Description
Developer of a biotechnology platform designed to advance crop improvement through precise, targeted recombination. The company offers proprietary breeding technologies that unlock natural genetic diversity, enabling breeders to deliver high-performing varieties that tackle challenges in productivity, sustainability, and disease resilience.
Contact Information
Website
www.meiogenix.comCorporate Office
- 9 Laboratory Drive
- Suite 267
- Durham, NC 27713
- United States
Corporate Office
- 9 Laboratory Drive
- Suite 267
- Durham, NC 27713
- United States
Meiogenix Timeline
Meiogenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | 13-Oct-2025 | $17.6M | In Progress | Generating Revenue | ||
| 8. Accelerator/Incubator | 25-Feb-2026 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A1) | 05-Dec-2024 | Completed | Startup | |||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Later Stage VC (Series A) | 18-Aug-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 20-Sep-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 26-Nov-2010 | $1.65M | $1.65M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Meiogenix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Shares A | ||||||||
| Shares P | ||||||||
| Shares P | ||||||||
| Shares P | 6,082 | $0.102096 | $226.88 | $226.88 | $226.88 | 8.11% | ||
| Shares P | 3,375 | $0.102096 | $363.01 | $363.01 | $363.01 | 4.5% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Meiogenix Comparisons
Industry
Financing
Details
Meiogenix Competitors (6)
One of Meiogenix’s 6 competitors is Ohalo (Other Agriculture), a Venture Capital-Backed company based in Aptos, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ohalo (Other Agriculture) | Venture Capital-Backed | Aptos, CA | ||||
| Verinomics | Venture Capital-Backed | New Haven, CT | ||||
| Hudson River Biotechnology | Venture Capital-Backed | Wageningen, Netherlands | ||||
| Tropic (Horticulture) | Venture Capital-Backed | Norwich, United Kingdom | ||||
| Cibus (Agriculture) | Formerly VC-backed | San Diego, CA |
Meiogenix Patents
Meiogenix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023288913-A1 | Induction of meiotic recombination using a crispr system | Pending | 24-Jun-2022 | ||
| EP-4544034-A1 | Induction of meiotic recombination using a crispr system | Pending | 24-Jun-2022 | ||
| US-20260125698-A1 | Induction of meiotic recombination using a crispr system | Pending | 24-Jun-2022 | ||
| WO-2023247773-A1 | Induction of meiotic recombination using a crispr system | Inactive | 24-Jun-2022 | ||
| AU-2021277562-A1 | Use of a deficient fusion protein for nuclease activity so as to induce meiotic recombinations | Pending | 20-May-2020 | C12N9/22 |
Meiogenix Signals
Meiogenix Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Center For Entrepreneurial Development | Accelerator/Incubator | |||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Sofinnova Partners | Venture Capital | Minority | ||
| Center for Life Science Ventures | Accelerator/Incubator |
Meiogenix FAQs
-
When was Meiogenix founded?
Meiogenix was founded in 2010.
-
Where is Meiogenix headquartered?
Meiogenix is headquartered in Durham, NC.
-
What is the size of Meiogenix?
Meiogenix has 21 total employees.
-
What industry is Meiogenix in?
Meiogenix’s primary industry is Other Agriculture.
-
Is Meiogenix a private or public company?
Meiogenix is a Private company.
-
What is Meiogenix’s current revenue?
The current revenue for Meiogenix is .
-
How much funding has Meiogenix raised over time?
Meiogenix has raised $24.8M.
-
Who are Meiogenix’s investors?
Center For Entrepreneurial Development, Alexandria Venture Investments, Casdin Capital, Sofinnova Partners, and Center for Life Science Ventures are 5 of 10 investors who have invested in Meiogenix.
-
Who are Meiogenix’s competitors?
Ohalo (Other Agriculture), Verinomics, Hudson River Biotechnology, Tropic (Horticulture), and Cibus (Agriculture) are some of the 6 competitors of Meiogenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process